How many studies have been conducted on Arabinofuranosylcytosine Triphosphate?

BiohacksAI has indexed 22 PubMed studies on Arabinofuranosylcytosine Triphosphate. 14% of studies involve human subjects.

What are the main research areas for Arabinofuranosylcytosine Triphosphate?

The primary research domains for Arabinofuranosylcytosine Triphosphate are 🔬 Oncology, 🧠 Memory, 🧠 Learning. This is based on analysis of 22 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Arabinofuranosylcytosine Triphosphate

A triphosphate nucleotide analog which is the biologically active form of CYTARABINE. It inhibits nuclear DNA synthesis.

22+ PubMed studies analyzed · Evidence Score: 28.1

Research Domains

Arabinofuranosylcytosine Triphosphate has been studied across 3 research domains including 🔬 Oncology, 🧠 Memory, 🧠 Learning. The primary research focus is 🔬 Oncology with 36% of studies addressing this area.

Loading evidence profile...

This evidence profile for Arabinofuranosylcytosine Triphosphate is generated deterministically from 22 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.